Mangalam Drugs & Organics Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 977.099 million compared to INR 673.033 million a year ago. Net income was INR 110.87 million compared to INR 8.079 million a year ago. Basic earnings per share from continuing operations was INR 7 compared to INR 0.51 a year ago. For the half year, total revenue was INR 2,020.053 million compared to INR 1,323.843 million a year ago. Net income was INR 193.825 million compared to INR 15.472 million a year ago. Basic earnings per share from continuing operations was INR 12.25 compared to INR 0.98 a year ago.